A B S T R A C ' Erythrocyte survival studies of complement-coated radiolabeled erythrocytes have shown rapid removal of these cells from the peripheral blood with a return of these cells into the circulation within a few hours. We studied complement-coated human erythrocytes and measured surface charge and deformability, two parameters believed to be important in erythrocyte survival. Erythrocytes were coated with complement by two in vitro techniques: the addition of (a) low ionic strength sucrose, and (b) IgM cold agglutinins.
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Erythrocytes obtained from three patients with cold agglutinin disease were used as a source of in vivo complement-coated cells. No difference was found in surface charge as measured by electrophoretic mobility between erythrocytes from normal subjects and complementcoated erythrocytes from any of the three sources. When deformability was measured by filtration through 3-Mm polycarbonate sieves, marked decreases in deformability were found in complement-coated erythrocytes. The filtration returned toward control levels by incubating the complement-coated erythrocytes in serum for 1 h and correlated with decreases in immune adherence. Using screen filtration pressure as a measure of deformability, a positive correlation between number of C3 molecules per erythrocyte and decreased deformability was found. C3b appeared responsible for the decreased deformability of the erythrocytes, since conversion of C3b to C3d resulted in a return of deformability toward normal. The INTRODUCTION Complement-fixing antibodies adversely affect erythrocytes in vivo either by the production of a membrane lesion resulting in acute osmotic intravascular lysis, or by inducing a membrane change allowing retention and extravascular destruction of the altered erythrocyte by the reticuloendothelial system. Survival studies of erythrocytes coated with antibody and complement, such that there was little intravascular lysis, have shown rapid sequestration of these cells in the microvasculature and reappearance of these erythrocytes in the circulation within several hours (1, 2) . It has been postulated that the temporary sequestration involved the binding of complement-coated erythrocytes to C3b receptors on macrophages with subsequent modification of active C3b by a serum C3b inactivator (C3bINA),7 causing release of the cells into the general circulation (3). We studied two membrane biophysical parameters of human erythrocytes possibly associated with the sequestration phenomena, surface charge and deformability, and the influence of complement on these parameters. (3) 2.08 ±0.02 * Number of samples.
METHODS

RESULTS
Electrophoretic mobility. There was no significant difference in electrophoretic mobility in phosphate-sorbitol buffer between normal erythrocytes and those fixed with complement in vitro ( Table I ). The presence of complement on the cells was confirmed by a direct Coombs' test using rabbit antihuman C3 antibody. The electrophoretic mobility of in vivo complement-coated erythrocyte from three patients with cold agglutinin disease fell within the control range.
The study of in vitro complement-coated erythrocytes was repeated, using high ionic strength buffers with divalent cations (Table II) . The low ionic strength method of complement attachment was used. Again, there was no difference in net negative surface charge between normal and complement-coated erythrocytes. No difference was seen in a pH-electrophoretic mobility curve between pH 4-9 for normal and complement-coated erythrocytes. Reduction of pH below 4 produced inconsistent results because of rapid hemolysis.
Deformability. Complement-coated human erythrocytes had decreased deformability as measured by filterability through 3-sum polycarbonate sieves (Table III) . This effect was independent of the method of complement fixation, i.e., low ionic strength or IgM cold agglutinin. The results using a cold agglutinin for complement fixation were independent of variations in antibody or fresh serum concentration during the incubation. The effect We then correlated the number of C3 molecules per erythrocyte to changes in deformability. Since filtration times greater than 400 s included samples that were not filterable along with those in which less than 2 ml filtered, a correlation coefficient with C3 could not be calculated from the data obtained by this technique. Therefore, a modified Swank screen filtration apparatus was used, using 3-,gm polycarbonate sieves as a screen. As shown in Fig. 1 , the amount of C3 bound to erythrocytes correlated positively with the filtration pressure (r = 0.725, P = 0.001). Bound C3b was inactivated by incubation in serum and the inactivation was monitored by diminished immune adherence to leukocytes suspended in a glass wool column and increases in measurable C3b to C3b sites on erythrocytes. As shown in Table IV , filtration time of complement-coated erythrocytes returns toward control levels after C3b inactivation, and correlates with reduction in immune adherence. In all cases, binding of control erythrocytes to the column was less than 10%. Heated serum also was able to return the filtration time toward control levels. The reduction in immune adherence in Table IV was associated with a 97% mean reduction in C3b molecules per cell and a 96% mean increase in C3d molecules per cell.
Abnormalities in erythrocyte filtration time of three patients with chronic cold agglutinin disease correlated with the patients' clinical status (Table V) . J. B., who was the most seriously ill (with anemia, jaundice, reticulocytosis, and marked cold intolerance), had marked filtration abnormalities both with 3 and 5-jim filters, whereas C. McD. was not symptomatic and had only a minor abnormality in filtration time through 3 Am filters. DISCUSSION The temporary sequestration in the microvasculature of complement-coated erythrocytes has been described in previous investigations. In human erythrocyte survival studies, 25-40% of low ionic strength complementcoated erythrocytes were rapidly removed from the circulation, with a ti of about 30 s (2). This sequestration was temporary, and the cells began to reappear in the general circulation within 20 min, often entirely reappearing in 3 days. In a patient with chronic cold agglutinin disease, sensitization of autologous erythrocytes in vitro with the patient's antibody produced a rapid clearance of the cells from the circulation, total reappearance within 24 h, and thereafter a normal erythrocyte survival (1) . Increasing the extent of complement coating eliminated approximately 30% of the cells, but those reappearing survived normally. Brown, Lachmann, and Dacie (3) studied the effect of human cold agglutinin on erythrocyte survival in rabbits and found that some of the sequestered erythrocytes were phagocytized in the livers and others released as damaged spherocytic cells. They concluded that the presence of fixed C3b was required for reticuloendothelial sequestration. Studies in guinea pigs have also stressed the importance of C3b in sequestration of complementcoated erythrocytes when complement-fixing antibody was present (16, 17) , and these studies have recently been confirmed in man (18) .
One membrane property postulated as important in erythrocyte survival is its net negative surface charge (19) . In human erythrocytes, the negative charge is largely due to ionized neuraminic acid (20) . Complement-fixation has been found to alter the net negative surface charge in heterologous systems of cells with complement and antibodies. Forrester, Dumonde, and Ambrose (11) studied the effect of rabbit antibody and guinea pig complement on mouse ascites tumor cells. Okada, Kojima, Yoshida, and Nishioka (10) found changes in surface charge of sheep erythrocytes using unfractionated rabbit antibody and the stepwise addition of purified guinea pig complement. In contrast to these studies, only human erythrocytes and proteins were used in our studies, and antibody did not remain attached to the cells. We found no changes in either the net negative surface charge of complement-coated erythrocytes or differences in the influence of pH on electrophoretic mobility. However, although we found no changes in net negative surface charge of complement-coated human erythrocytes, local perturbations of membrane structure induced by complement could promote areas of increased and decreased anionic density, with the overall charge remaining constant. The relationship of erythrocyte deformability to erythrocyte survival has been extensively explored and described (21) . Changes in surface area to volume ratio, intracellular inclusions, or intrinsic membrane rigidity of erythrocytes, promote stasis in the microvasculature with subsequent destruction by the reticuloendothelial system. The effect of complement fixation of erythrocyte deformability is striking. Increasing amounts of complement, added either by low ionic strength, IgM cold agglutinins, or in vivo in patients with cold agglutinin disease, produced decreased erythrocyte deformability as measured in either a flow rate or positive pressure system. This was not caused by antibody since IgM cold agglutinin complement-coated cells had no demonstrable antibody on their surface. It was not believed to be caused by C1 or C2 because washing the cells with VBS-G-EDTA or incubating for 2 h at 370C in VBS-G-M++ had no effect on their deformability. Further, these changes seemed directly related to levels of erythrocyte-bound C3 and the abnormalities were reversed by inactivation of C3b. Three additional findings suggest that C3b was responsible for changes in erythrocyte deformability: (a) sequestration of in vivo complement-coated erythrocytes occurs in C6-deficient rabbits but not in C3-depleted rabbits (3) or guinea pigs (16, 17) ; (b) the presence of a C3 inactivator is well described (22) ; and (c) human erythrocytes coated with IgM antibody and C3b are rapidly cleared from the circulation, whereas those erythrocytes coated with antibody and C3d are not cleared (18) . Incubation of the erythrocytes in VBS-G-M++, a procedure that inactivates bound C5 (23), failed to correct the filtration abnormality. Other factors that are known to decrease erythrocyte deformability (21) were not found; ancillary studies showed no significant cellular changes or aggregation by phase microscopy, no size differences by mean corpuscular volume or osmotic fragility measurements, no intracellular inclusions, and no decreased ATP levels in the complement-coated erythrocytes. Although interaction between erythrocytes coated with C3b has been described (24), it was not seen in our test system. Therefore, the defect was believed to reside in the membrane.
The cause of the decreased deformability is not clear. C5 and C6 have been found on erythrocytes of patients with autoimmune hemolytic anemias without affecting erythrocyte survival or membrane integrity (25) . By the stepwise addition of purified complement components, Polley, Muller-Eberhard, and Feldman (26) found an ultrastructural lesion in the erythrocyte membrane when the C5 stage was reached. The lesion was not removed by trypsin and therefore was felt to be intrinsic to the membrane and not an arrangement of complement molecules on the membrane. However, incubation of erythrocytes in buffer failed to correct the abnormality in filtration, and it is therefore unlikely that C5 plays a major role in the deformability changes. Complement has been alleged to affect membrane lipids (27, 28) , but this work has not been confirmed by others (29) (30) (31) (32) . In any event, the rapidity of the correction in deformability upon incubation in serum makes it unlikely that extensive lipid changes play a role.
The presence of large amounts of complement on the erythrocyte membrane may interfere with deformability. Accretion of C3b in plaques may influence deformability by sheer bulk. When C3bINA (21) reacts with C3b (mol wt 185,000) to produce free C3c (mol wt 150,000) and bound C3d (mol wt 35,000), the membrane may regain some of its plasticity. The filtration time of complement-coated erythrocytes incubated in serum improved but never became normal. Large amounts of C3d, as seen in the patients with chronic cold agglutinin disease, may interfere with erythrocyte deformability. In our three patients with chronic cold agglutinin disease, we found elevated levels of C3d and C3b on their erythrocytes, the latter correlating with increased immune adherence. These changes were found repeatedly despite careful sample collection. These changes probably reflect the sensitivity of the method used for estimating C3b and C3d. With this assay, factors such as complement source would give different absolute numbers in different laboratories.
Decreased deformability of complement-coated erythrocytes could explain the difficulty these cells have in traversing the microvasculature. This stasis or delay in the microvasculature would prolong exposure to C3b receptors (33, 34) on macrophages and thereby promote immune adherence. If the erythrocyte becomes attached to a macrophage, it may be ingested or partially damaged. If not ingested, C3bINA cleaves off C3c, and the erythrocyte re-enters the circulation as a partially damaged spherocyte or a completely normal cell. The time-course of C3b inactivation is consistent with the clinical erythrocyte survival studies requiring i to 2 h for the return of the sequestered cells in the circulation (1) . These cells may contain immunologically identifiable complement components on their membrane but they are predominantly of the C3d type.
